Cenova Capital
千骥资本
Cenova Capital (千骥资本) is a Chinese healthcare-focused venture capital firm, though elsewhere's corpus does not contain a direct profile of the fund itself. The available material only captures its investment activity through deal announcements published by portfolio companies and co-investors.
Per these sources, Cenova has been an active investor in digital health and medical technology since at least 2018. It led a round in Weimai (微脉), a local medical services platform, in September 2018 , and subsequently participated in multiple follow-on rounds for the company in 2019, 2020, and 2025 . Its other disclosed investments include Youwei Biology (优微生物), a soluble microneedle drug delivery company, which it backed exclusively in a Series B round in 2022 , and Pulnovo Medical, a cardiovascular device company, in a 2022 financing alongside OrbiMed, LAV, and Gaorong Capital . Shen Xiaoyin (沈小寅) is identified as a representative of the firm in coverage of the Weimai deals .
The firm's investment pattern suggests a concentration on care delivery and medtech, with repeated follow-on commitments to portfolio companies. Elsewhere's corpus does not cover Cenova's founding date, fund size, or full team composition.
AI-generated — may contain errors, please verify.
Coverage
MaHui Member WeiMai Closes RMB 200 Million Series D Round, Existing Shareholder Source Code Capital Continues to Increase Stake
Pulnovo Medical Closes New Tens-of-Millions USD Funding Round to Accelerate Global Expansion
It secured a foothold in global markets and made substantial headway on multiple fronts in 2022.
Code Moment | Youwei Biology Announces Close to 100 Million RMB Series B Round; Source Code Capital Led Series A
Advancing the Commercial Application of Dissolvable Microneedle Technology
Source Code Capital portfolio company WeiMai announced the completion of a $100 million Series C+ funding round, with existing shareholder Source Code Capital continuing to increase its stake.
Making healthcare services more accessible, now covering 160+ cities across China with deep partnerships with 1,000 public hospitals nationwide.
Source Code Capital portfolio company WeiMai announced the completion of a new $100 million series funding round, with existing shareholder Source Code Capital continuing to increase its stake.
A pioneer and leader in "Internet + Healthcare" service platforms. Its services cover more than 150 million people, with 100,000 doctors on the platform offering a wide range of healthcare service SKUs.
Meituan IPO on Hong Kong Exchanges and Clearing Limited; 4 Companies Complete Funding Rounds; 8 Companies Win 12 Awards | Source Code Capital Monthly · September
**Source Code Capital Chronicles** — recording our teammates' step-by-step progress, sharing the joy of growth, and looking toward an even brighter future.
